These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 17914700)
1. Effect of smoking on prognostic factors of transitional cell carcinoma of the bladder. Mohseni MG; Zand S; Aghamir SM Urol J; 2004; 1(4):250-2. PubMed ID: 17914700 [TBL] [Abstract][Full Text] [Related]
2. Clinical-pathological differences and smoking habit depending on gender in a cohort of patients with transitional cell carcinoma of the bladder: retrospective study. Lorente JA; Bielsa O; Rijo E; Cortadellas R; Nohales G; Francés A; Juanpere N; Lloreta J; Arango O Arch Esp Urol; 2011 Jun; 64(5):427-33. PubMed ID: 21705815 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder. Jalali Nadoushan MR; Taheri T; Jouian N; Zaeri F Urol J; 2007; 4(3):151-4. PubMed ID: 17987577 [TBL] [Abstract][Full Text] [Related]
4. Is bladder cancer more common among opium addicts? Aliasgari MA; Kaviani A; Gachkar L; Hosseini-Nassab SR Urol J; 2004; 1(4):253-5. PubMed ID: 17914701 [TBL] [Abstract][Full Text] [Related]
5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
7. Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association. Hinotsu S; Akaza H; Miki T; Fujimoto H; Shinohara N; Kikuchi E; Mizutani Y; Koga H; Okajima E; Okuyama A; Int J Urol; 2009 Jan; 16(1):64-9. PubMed ID: 19054170 [TBL] [Abstract][Full Text] [Related]
8. p53 protein in serum and urine samples of patients with bladder transitional cell carcinoma and its overexpression in tumoral tissue. Darabi M; Tayebi Meibodi N; Mahdavi R; Arab D Urol J; 2006; 3(4):216-9. PubMed ID: 17559044 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580 [TBL] [Abstract][Full Text] [Related]
10. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962 [TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of transitional cell carcinoma among Israeli Arabs]. Vainrib M; Zelokovsky E; Erlich N; Eidelberg I; Kaneti J; Leibovitch I Harefuah; 2006 Jan; 145(1):18-21, 79. PubMed ID: 16450718 [TBL] [Abstract][Full Text] [Related]
12. Association between marijuana use and transitional cell carcinoma. Chacko JA; Heiner JG; Siu W; Macy M; Terris MK Urology; 2006 Jan; 67(1):100-4. PubMed ID: 16413342 [TBL] [Abstract][Full Text] [Related]
13. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder. Jamshidian H; Kor K; Djalali M Urol J; 2008; 5(4):243-7. PubMed ID: 19101898 [TBL] [Abstract][Full Text] [Related]
14. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer. Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091 [TBL] [Abstract][Full Text] [Related]
15. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer. Ahirwar D; Kesarwani P; Manchanda PK; Mandhani A; Mittal RD Cancer Genet Cytogenet; 2008 Jul; 184(1):1-8. PubMed ID: 18558283 [TBL] [Abstract][Full Text] [Related]
16. Differences in tumor characteristics and prognosis in newly diagnosed Ta, T1 urothelial carcinoma of bladder according to patient age. Cho KS; Hwang TK; Kim BW; Yoon DK; Chang SG; Kim SJ; Park JY; Cheon J; Sung GT; Hong SJ; Urology; 2009 Apr; 73(4):828-32, 832.e1. PubMed ID: 19195693 [TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma. Serretta V; Altieri V; Morgia G; Allegro R; Ruggirello A; Di Lallo A; Carrieri G; Melloni D; Urol Int; 2009; 82(3):318-23. PubMed ID: 19440021 [TBL] [Abstract][Full Text] [Related]
18. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis. Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110 [TBL] [Abstract][Full Text] [Related]
19. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma. Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551 [TBL] [Abstract][Full Text] [Related]
20. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. Novara G; De Marco V; Dalpiaz O; Gottardo F; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V BJU Int; 2008 Jun; 101(11):1368-74. PubMed ID: 18241252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]